1. A controlled trial of antidepressants in patients with Parkinson’s disease and depression

   • John C. Morgan
   • Kapil D. Sethi

   Clinical Trials Report 09 June 2009 Pages: 263 - 265

2. Bilateral deep brain stimulation versus best medical therapy for patients with advanced Parkinson’s disease

   • Shyamal H. Mehta
   • Kapil D. Sethi

   Clinical Trials Report 09 June 2009 Pages: 266 - 267

3. Is it time for drug sensitivity genetic screening?

   • Carl W. Bazil

   Clinical Trials Report 09 June 2009 Pages: 268 - 269

4. An update on essential tremor

   • Rodger J. Elble
   • Günther Deuschl

   OriginalPaper 09 June 2009 Pages: 273 - 277

5. What’s new in dystonia?

   • Vicki Shanker
   • Susan B. Bressman

   OriginalPaper 09 June 2009 Pages: 278 - 284

6. Paraneoplastic movement disorders

   • Shyamal H. Mehta
   • John C. Morgan
   • Kapil D. Sethi

   OriginalPaper 09 June 2009 Pages: 285 - 291

7. Cell-based therapies in Parkinson’s disease

   • Paul Greene

   OriginalPaper 09 June 2009 Pages: 292 - 297

8. New insights into the organization of the basal ganglia

   • James B. Koprich
   • Tom H. Johnston
   • Jonathan M. Brotchie

   OriginalPaper 09 June 2009 Pages: 298 - 304

9. Depression and epilepsy: Do glucocorticoids and glutamate explain their relationship?

   • Andres M. Kanner

   OriginalPaper 09 June 2009 Pages: 307 - 312

10. Alternative approaches to epilepsy treatment

    • Caitlin McElroy-Cox

    OriginalPaper 09 June 2009 Pages: 313 - 318

11. Epilepsy in the developing world

    • Arturo Carpio
    • W. Allen Hauser

    OriginalPaper 09 June 2009 Pages: 319 - 326

12. An update on brain stimulation for epilepsy

    • Christopher Todd Anderson
    • Kathryn Davis
    • Gordon Baltuch

    OriginalPaper 09 June 2009 Pages: 327 - 332

13. Bioequivalence of antiepileptic drugs: How close is close enough?

    • Barry E. Gidal

    OriginalPaper 09 June 2009 Pages: 333 - 337